Fresenius SE & Co. KGaA / Key word(s): Forecast
Fresenius SE & Co. KGaA: Fresenius expects mid-single digit organic growth in the medium-term, after strong investment year 2019
06-Dec-2018 / 22:30 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Fresenius expects mid-single digit organic growth in the medium-term, after strong investment year 2019
Current Group expectations for FY 2019
Current Group expectations
From 2020 onwards, Fresenius now expects sustainable organic Group sales growth in the mid-single digits. Group net income2,3 is expected to grow organically slightly faster than sales. Upon Fresenius Kabi’s biosimilars business breaking even, Fresenius expects an acceleration of Group earnings growth. Unlike previous mid-term targets, these expectations exclude the effect of small- to medium-sized acquisitions.
Fresenius will announce detailed FY 2019 financial guidance and mid-term targets with the release of its FY 2018 results on February 20, 2019.
For additional information on the performance indicators used please refer to our website at https://www.fresenius.com/alternative-performance-measures.
(Financial statements according to IFRS)
Fresenius SE & Co. KGaA,
Bad Homburg v.d.H., December 6, 2018
End of note
06-Dec-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
|Company:||Fresenius SE & Co. KGaA|
|61352 Bad Homburg v.d.H.|
|Phone:||+49 (0)6172 608-2485|
|Fax:||+49 (0)6172 608-2488|
|Listed:||Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Hamburg, Hanover, Stuttgart, Tradegate Exchange; Luxembourg Stock Exchange|
|End of Announcement||DGAP News Service|